NEUBERGER BERMAN GROUP LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1465109
NEW YORK, NY
Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,026,044
-$4,759,363 QoQ
Shares Held
98,467
-51.7% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#109
of 499 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $1,452,567,393 across 97 Biotechnology names. ARWR ranks #27 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
559,445 | $277,893,114 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
421,976 | $263,118,914 | |
| 3 | TECH |
BIO-TECHNE Corp
|
2,844,692 | $200,977,489 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
248,355 | $78,502,531 | |
| 5 | CAI |
Caris Life Sciences, Inc.
|
3,590,963 | $63,990,960 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
633,533 | $50,232,830 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
552,158 | $41,124,727 | |
| 8 | INSM |
INSMED Inc
|
378,816 | $40,389,361 |
All Filings in ARWR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,026,044 | 98,467 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $12,785,407 | 203,914 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $6,664,559 | 100,385 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $461,648 | 13,385 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $199,901 | 12,652 | Shares | Defined | 2025-08-25 | |
| 2024-09-30 | $3,637,801 | 187,806 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $5,136,118 | 167,847 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $3,468,217 | 129,074 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,985,200 | 223,926 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,253,225 | 246,190 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,397,663 | 207,043 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,542,994 | 258,487 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $8,751,515 | 248,552 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,865,787 | 258,008 | Shares | Defined | 2022-05-23 | |
| 2021-12-31 | $18,143,458 | 273,657 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $17,721,254 | 283,858 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $17,779,797 | 214,680 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,224,730 | 244,680 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $14,537,725 | 189,466 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $5,697,053 | 132,305 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,528,449 | 81,696 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||